Fragment Length of Circulating Tumor DNA

PLoS Genetics

Volumn 12, Issue 7, 2016, Pages

  Underhill, Hunter R ^a,b   Kitzman, Jacob O ^c,d   Hellwig, Sabine ^e   Welker, Noah C ^e   Daza, Riza ^c   Baker, Daniel N ^e   Gligorich, Keith M ^a,e   Rostomily, Robert C ^b   Bronner, Mary P ^a,e   Shendure, Jay ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CELL FREE DNA; CIRCULATING TUMOR DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG CANCER; MALE; MELANOMA; MUTANT; NONHUMAN; PERIODICITY; RAT; WILD TYPE; ANIMAL; BLOOD; CANCER TRANSPLANTATION; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; LUNG TUMOR; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR CELL LINE;

ALLELES; ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, NEOPLASM; GLIOBLASTOMA; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MUTATION; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS B-RAF; RATS;

EID: 84982840399     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006162     Document Type: Article

References (39)

1. Schwarzenbach H, Hoon DS, Pantel K, Cell-free nucleic acids as biomarkers in cancer patients. Nature reviews. 2011;11(6):426–37. Epub 2011/05/13. doi: 10.1038/nrc3066 nrc3066 [pii]. 21562580. 21562580
2. Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368(13):1199–209. Epub 2013/03/15. doi: 10.1056/NEJMoa121326123484797.
3. Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012;4(136):136ra68. Epub 2012/06/01. doi: 10.1126/scitranslmed.3003726 4/136/136ra68 [pii]. 22649089.
4. Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, et al. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann N Y Acad Sci. 2006;1075:185–90. Epub 2006/11/17. 1075/1/185 [pii] doi: 10.1196/annals.1368.02517108210.
5. Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, et al. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol. 2008;27(8):415–21. Epub 2008/08/13. doi: 10.1089/dna.2008.074418694299.
6. Beau-Faller M, Gaub MP, Schneider A, Ducrocq X, Massard G, Gasser B, et al. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. International journal of cancer. 2003;105(3):361–70. Epub 2003/04/22. doi: 10.1002/ijc.1107912704670.
7. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003;21(21):3902–8. Epub 2003/09/26. doi: 10.1200/JCO.2003.02.006 JCO.2003.02.006 [pii]. 14507943.
8. Huang ZH, Li LH, Hua D, Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer letters. 2006;243(1):64–70. Epub 2006/01/18. S0304-3835(05)01028-1 [pii] doi: 10.1016/j.canlet.2005.11.02716412565.
9. Tug S, Helmig S, Menke J, Zahn D, Kubiak T, Schwarting A, et al. Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients. Cell Immunol. 2014;292(1–2):32–9. Epub 2014/09/23. doi: 10.1016/j.cellimm.2014.08.002 S0008-8749(14)00127-0 [pii]. 25243646.
10. Breitbach S, Tug S, Simon P, Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med. 2012;42(7):565–86. Epub 2012/06/15. doi: 10.2165/11631380-000000000-00000 1 [pii]. 22694348.
11. Taniguchi K, Uchida J, Nishino K, Kumagai T, Okuyama T, Okami J, et al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin Cancer Res. 2011;17(24):7808–15. Epub 2011/10/07. doi: 10.1158/1078-0432.CCR-11-1712 1078-0432.CCR-11-1712 [pii]. 21976538.
12. Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, et al. Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Res Treat. 2010;120(2):461–7. Epub 2010/01/29. doi: 10.1007/s10549-010-0747-920107891.
13. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24. Epub 2014/02/21. doi: 10.1126/scitranslmed.3007094 6/224/224ra24 [pii]. 24553385; PubMed Central PMCID: PMC4017867.
14. Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med. 2014;20(4):430–5. doi: 10.1038/nm.351124658074.
15. Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol. 2016. doi: 10.1038/nbt.352027018799.
16. Mouliere F, Robert B, Arnau Peyrotte E, Del Rio M, Ychou M, Molina F, et al. High fragmentation characterizes tumour-derived circulating DNA. PLoS One. 2011;6(9):e23418. Epub 2011/09/13. doi: 10.1371/journal.pone.0023418 PONE-D-11-07649 [pii]. 21909401; PubMed Central PMCID: PMC3167805.
17. Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A. 2015;112(11):E1317–25. Epub 2015/02/04. doi: 10.1073/pnas.1500076112 1500076112 [pii]. 25646427; PubMed Central PMCID: PMC4372002.
18. Wakimoto H, Kesari S, Farrell CJ, Curry WT, Jr.Zaupa C, Aghi M, et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer research. 2009;69(8):3472–81. Epub 2009/04/09. 0008-5472.CAN-08-3886 [pii] doi: 10.1158/0008-5472.CAN-08-388619351838; PubMed Central PMCID: PMC2785462.
19. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, et al. TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 2010;9:194. Epub 2010/07/22. 1476-4598-9-194 [pii] doi: 10.1186/1476-4598-9-19420646316; PubMed Central PMCID: PMC2920263.
20. Underhill HR, Rostomily RC, Mikheev AM, Yuan C, Yarnykh VL, Fast bound pool fraction imaging of the in vivo rat brain: Association with myelin content and validation in the C6 glioma model. NeuroImage. 2011;54(3):2052–65. Epub 2010/10/30. S1053-8119(10)01358-3 [pii] doi: 10.1016/j.neuroimage.2010.10.06521029782; PubMed Central PMCID: PMC3008309.
21. Haacke EM, Brown RW, Thompson MR, Venkatesan R, Magnetic Resonance Imaging: Physical Principles and Sequence Design. New York: John Wiley & Sons, Inc; 1999.
22. Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J, Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell. 2016;164(1–2):57–68. doi: 10.1016/j.cell.2015.11.05026771485; PubMed Central PMCID: PMCPMC4715266.
23. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute. 2005;97(5):339–46. doi: 10.1093/jnci/dji05515741570.
24. Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 2010;38(18):6159–75. Epub 2010/05/25. doi: 10.1093/nar/gkq421 gkq421 [pii]. 20494973; PubMed Central PMCID: PMC2952865.
25. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer research. 2001;61(4):1659–65. Epub 2001/03/14. 11245480.
26. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, et al. Apoptosis: molecular regulation of cell death. Eur J Biochem. 1996;236(1):1–26. Epub 1996/02/15. 8617251.
27. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2(61):61ra91. Epub 2010/12/15. doi: 10.1126/scitranslmed.3001720 2/61/61ra91 [pii]. 21148127.
28. Zheng YW, Chan KC, Sun H, Jiang P, Su X, Chen EZ, et al. Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem. 2012;58(3):549–58. Epub 2011/11/05. doi: 10.1373/clinchem.2011.169318 clinchem.2011.169318 [pii]. 22052939.
29. Widom J, A relationship between the helical twist of DNA and the ordered positioning of nucleosomes in all eukaryotic cells. Proc Natl Acad Sci U S A. 1992;89(3):1095–9. 1736292; PubMed Central PMCID: PMCPMC48392.
30. Underhill HR, Yuan C, Hayes CE, A combined solenoid-surface RF coil for high-resolution whole-brain rat imaging on a 3.0 tesla clinical MR scanner. Magn Reson Med. 2010;64(3):883–92. 20535812. doi: 10.1002/mrm.22466
31. Skinner TE, Glover GH, An extended two-point Dixon algorithm for calculating separate water, fat, and B0 images. Magn Reson Med. 1997;37(4):628–30. 9094088.
32. Yarnykh VL, Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med. 2007;57(1):192–200. 17191242.
33. Morrison C, Henkelman RM, A model for magnetization transfer in tissues. Magn Reson Med. 1995;33(4):475–82. 7776877.
34. Sled JG, Pike GB, Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med. 2001;46(5):923–31. 11675644.
35. Yarnykh VL, Yuan C, Cross-relaxation imaging reveals detailed anatomy of white matter fiber tracts in the human brain. NeuroImage. 2004;23(1):409–24. 15325389.
36. Li H, Durbin R, Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. Epub 2009/05/20. doi: 10.1093/bioinformatics/btp324 btp324 [pii]. 19451168; PubMed Central PMCID: PMC2705234.
37. Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, Ahn EH, et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nat Protoc. 2014;9(11):2586–606. doi: 10.1038/nprot.2014.17025299156; PubMed Central PMCID: PMCPMC4271547.
38. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–9. doi: 10.1093/bioinformatics/btp35219505943; PubMed Central PMCID: PMCPMC2723002.
39. Milbury CA, Zhong Q, Lin J, Williams M, Olson J, Link DR, et al. Determining lower limits of detection of digital PCR assays for cancer-related gene mutations. Biomlecular Detection and Quantification. 2014;1:8–22.